Cubist Systematic Strategies, LLC Avadel Pharmaceuticals PLC Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$12.55 - $17.22 $2 Million - $2.74 Million	159,281 Added 1722.52%	168,528 $2.85 Million
Q4 2023 Feb 14, 2024	SELL	$9.64 - $14.59 $90,018 - $136,241	-9,338 Reduced 50.24%	9,247 $130,000
Q3 2023 Nov 14, 2023	SELL	$10.3 - $15.99 $886,098 - $1.38 Million	-86,029 Reduced 82.23%	18,585 $191,000
Q2 2023 Aug 14, 2023	BUY	$8.48 - $16.48 $468,850 - $911,162	55,289 Added 112.09%	104,614 $1.72 Million
Q1 2023 May 15, 2023	SELL	$6.41 - $9.95 $691,542 - $1.07 Million	-107,885 Reduced 68.62%	49,325 $451,000
Q4 2022 Feb 14, 2023	BUY	$5.02 - $10.0 $529,113 - $1.05 Million	105,401 Added 203.44%	157,210 $1.13 Million
Q3 2022 Nov 14, 2022	BUY	$2.57 - $7.31 $133,149 - $378,723	51,809 New	51,809 $260,000
Q1 2022 May 16, 2022	SELL	$5.46 - $8.29 $225,880 - $342,957	-41,370 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$7.34 - $11.18 $171,733 - $261,578	23,397 Added 130.18%	41,370 $334,000
Q3 2021 Nov 15, 2021	BUY	$6.49 - $9.91 $116,644 - $178,112	17,973 New	17,973 $176,000
Q4 2020 Feb 16, 2021	SELL	$5.03 - $7.95 $346,164 - $547,119	-68,820 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$5.02 - $8.98 $345,476 - $618,003	68,820 New	68,820 $347,000
Q2 2020 Aug 14, 2020	SELL	$7.25 - $11.75 $111,113 - $180,080	-15,326 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$4.06 - $10.64 $62,223 - $163,068	15,326 New	15,326 $122,000
Q3 2018 Nov 14, 2018	SELL	$4.08 - $7.14 $44,145 - $77,254	-10,820 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$5.89 - $7.78 $63,729 - $84,179	10,820 New	10,820 $66,000
Q1 2018 May 15, 2018	SELL	$6.76 - $11.7 $74,238 - $128,489	-10,982 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$8.03 - $11.25 $52,588 - $73,676	-6,549 Reduced 37.36%	10,982 $90,000
Q3 2017 Nov 14, 2017	BUY	$8.35 - $10.5 $146,383 - $184,075	17,531	17,531 $184,000

Others Institutions Holding AVDL

# of Institutions

Shares Held

1.07M

Call Options Held

Put Options Held

View Full List

About AVADEL PHARMACEUTICALS PLC

Ticker AVDL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 60,581,300
Market Cap $661M
Description
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...

More about AVDL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account